Document Detail

The proteasome in terminal plasma cell differentiation.
MedLine Citation:
PMID:  22726544     Owner:  NLM     Status:  In-Data-Review    
The ability of eukaryotic cells to adapt to changing environmental conditions, respond to stimuli, and differentiate relies on their capacity to control the concentration, conformation, localization, and interaction of proteins, thereby reshaping their proteome. Protein degradation plays a critical role in maintaining protein homeostasis, and hence is carefully regulated. During the spectacular and demanding metamorphosis of activated B lymphocytes, expression programs are launched in coordinated waves, and adaptive strategies are deployed to prepare for antibody secretion. Surprisingly, though, despite increased demand for proteolysis, proteasome capacity collapses. As a result, antibody-secreting cells show symptoms of proteotoxic stress, and become extremely vulnerable to proteasome inhibition. The emerging concept that proteostenosis naturally follows B-cell activation has biological and immune implications, for it provides a model to dissect the integrated regulation of protein homeostasis, and a molecular counter limiting antibody responses, of use against autoimmune diseases. Mounting evidence linking proteotoxicity with proteasome vulnerability in malignant plasma cells visualizes strategies to understand responsiveness and obviate resistance to proteasome inhibition, with implications for the biology and therapy of plasma cell dyscrasias, namely, light chain amyloidosis and multiple myeloma.
Simone Cenci
Related Documents :
22294094 - Combined experimental and computational analysis of dna damage signaling reveals contex...
8640944 - Analysis of differentiation-associated proteins in rat bladder carcinogenesis.
7272964 - Scanning electron microscopic features of human urinary bladder cancer.
19130324 - A study on the cd(4) (+) cd (25) (+) regulatory t cells in patients with gastrointestin...
22457634 - The min system and nucleoid occlusion are not required for identifying the division sit...
17642524 - Receptivity of human choriocarcinoma jegiii cells and isolated trophoblast cells to hep...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Seminars in hematology     Volume:  49     ISSN:  1532-8686     ISO Abbreviation:  Semin. Hematol.     Publication Date:  2012 Jul 
Date Detail:
Created Date:  2012-06-25     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0404514     Medline TA:  Semin Hematol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  215-22     Citation Subset:  IM    
Copyright Information:
Copyright © 2012 Elsevier Inc. All rights reserved.
Division of Genetics and Cell Biology, DiBiT, San Raffaele Scientific Institute, and Università Vita-Salute San Raffaele, Milano, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Discovery and development of second-generation proteasome inhibitors.
Next Document:  Biologic impact of proteasome inhibition in multiple myeloma cells--from the aspects of preclinical ...